LARS Antikörper (N-Term)
Kurzübersicht für LARS Antikörper (N-Term) (ABIN2297311)
Target
Alle LARS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 183-213, N-Term
-
Kreuzreaktivität
- Maus
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Mo
-
Produktmerkmale
- LARS, NT (LARS, KIAA1352, Leucine-tRNA ligase, cytoplasmic, Leucyl-tRNA synthetase)
-
Aufreinigung
- Purified by saturated ammonium sulfate precipitation followed by dialysis against PBS.
-
Immunogen
- LARS antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 183-213 amino acids from the N-terminal region of human LARS.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- LARS (Leucyl-tRNA Synthetase (LARS))
-
Andere Bezeichnung
- LARS
-
NCBI Accession
- NP_064502
-
UniProt
- Q9P2J5
-
Pathways
- EGFR Signaling Pathway
Target
-